Devyser Diagnostics AB (OSTO:DVYSR) FCF Margin % : -86.98% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Devyser Diagnostics AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Devyser Diagnostics AB's Free Cash Flow for the three months ended in Mar. 2024 was kr-44.1 Mil. Devyser Diagnostics AB's Revenue for the three months ended in Mar. 2024 was kr50.7 Mil. Therefore, Devyser Diagnostics AB's FCF Margin % for the quarter that ended in Mar. 2024 was -86.98%.

As of today, Devyser Diagnostics AB's current FCF Yield % is -6.57%.

The historical rank and industry rank for Devyser Diagnostics AB's FCF Margin % or its related term are showing as below:

OSTO:DVYSR' s FCF Margin % Range Over the Past 10 Years
Min: -66.37 Med: -15.64 Max: 8.27
Current: -66.37

During the past 7 years, the highest FCF Margin % of Devyser Diagnostics AB was 8.27%. The lowest was -66.37%. And the median was -15.64%.

OSTO:DVYSR's FCF Margin % is ranked worse than
71.95% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: -10.54 vs OSTO:DVYSR: -66.37

Devyser Diagnostics AB FCF Margin % Historical Data

The historical data trend for Devyser Diagnostics AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devyser Diagnostics AB FCF Margin % Chart

Devyser Diagnostics AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

8.27

-4.24

-27.04

-52.37

-60.07

Devyser Diagnostics AB Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial												-66.08	-94.96	-35.33	-51.54	-86.98

Competitive Comparison of Devyser Diagnostics AB's FCF Margin %

For the Diagnostics & Research subindustry, Devyser Diagnostics AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Devyser Diagnostics AB's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Devyser Diagnostics AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Devyser Diagnostics AB's FCF Margin % falls into.

Devyser Diagnostics AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Devyser Diagnostics AB's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-101.7	/	169.3
	=	-60.07 %

Devyser Diagnostics AB's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-44.1	/	50.7
	=	-86.98 %

Devyser Diagnostics AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of Devyser Diagnostics AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Devyser Diagnostics AB (OSTO:DVYSR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Devyser Diagnostics AB (OSTO:DVYSR) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Instrumentvagen 19, Hagersten, SWE, 126 53

Website

https://www.devyser.com

Devyser Diagnostics AB is specialized in the development, manufacture and sale of market-leading genetic diagnostic kits.The products are used for complex DNA testing in the hereditary disease, oncology and post-transplantation monitoring fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.

Devyser Diagnostics AB (OSTO:DVYSR) Headlines

No Headlines